
Citi Upgrades Hims & Hers on Novo Nordisk GLP-1 Pact
Citi upgraded Hims & Hers Health to neutral from sell after its Novo Nordisk GLP-1 drugs deal reduces key risks, and raised the price target to $24, signaling potential upside for the stock.
All articles tagged with #stock upgrade

Citi upgraded Hims & Hers Health to neutral from sell after its Novo Nordisk GLP-1 drugs deal reduces key risks, and raised the price target to $24, signaling potential upside for the stock.

Freedom Capital Markets analyst Almas Almaganbetov upgraded Palantir (PLTR) from Sell to Buy after strong Q4FY25 results and upbeat guidance, saying AI agents pose no long-term risk to Palantir and setting a $170 price target (about 29% upside). The company topped EPS and revenue expectations driven by its AI Platform (AIP), while estimates for 2026–27 were raised; the move contrasted with mixed views from other analysts, and PLTR climbed about 1.7% after the upgrade.

Seaport Research Partners upgraded Intel to Buy with a $65 target, arguing Panther Lake CPUs built on the 18A process could help Intel regain market share in 2026. The upgrade adds to a growing wave of Buy ratings even as many analysts remain skeptical, with Intel stock having surged in early 2026 amid new product optimism and manufacturing progress.

Morgan Stanley doubles up its upgrade on a cybersecurity stock as it nears a pivotal inflection point, signaling potential upside for investors.

Shares of Plug Power surged 7.3% after an analyst upgrade citing potential profitability improvements, driven by cost savings and higher product prices, though the stock remains highly volatile and influenced by broader market trends.

Plug Power's stock rose after Clear Street upgraded its rating to Buy despite lowering its price target to $3, citing potential shareholder dilution and upcoming corporate decisions that could impact the stock. The broader market declined, and industry peers showed mixed results amid sector scrutiny.

Investors are locking in profits on a stock that has recently surged, while also increasing their holdings in a beaten-down stock that received an analyst upgrade, reflecting strategic adjustments amid market volatility.

Eli Lilly's stock (LLY) was upgraded following news that obesity drugs will now be covered by Medicare, potentially boosting the company's prospects in the pharmaceutical industry.

Jim Cramer has upgraded Microsoft stock and reports that the Starbucks CEO shared encouraging news he had been waiting to hear, indicating positive developments for both companies.

Microsoft stock (MSFT) has been upgraded to a buy rating by a top analyst ahead of the company's Q1 earnings report, indicating strong investor confidence and positive outlook for the company's upcoming financial results.

HSBC analysts have upgraded Nvidia stock to buy, predicting a 78% upside driven by an expanding market for AI graphics processing units and broader customer adoption beyond cloud providers, indicating strong growth potential in the AI race.

Morgan Stanley raised its price target on Alphabet (GOOGL) to $270, citing the company's leadership in AI and advancements in quantum computing, with positive signals in GenAI adoption and cloud growth, positioning Alphabet as a key AI winner.

Apple's stock has rebounded and reached a new high after positive reports on the iPhone 17's strong start and demand, especially for the Pro models, with analyst Daniel Ives raising his price target to $310 due to optimistic growth prospects and AI integration opportunities. Despite competition and geopolitical tensions, Apple is positioned for growth, particularly in China, driven by new product cycles and AI monetization strategies.

Tesla stock surged after Baird and Goldman Sachs raised their price targets, with Baird's analyst highlighting a potential 'physical AI inflection' that could transform Tesla into more than just a car manufacturer, leading to a 71% increase in forecasted stock price. Despite the rally and positive news, the stock remains above the average analyst target, with some caution about its sustainability and competition, and a consensus rating of Hold.

Tesla's stock received upgrades from Baird and Goldman Sachs, with Baird raising its price target to $548 citing a 'physical AI inflection' and Goldman Sachs increasing its target to $395, driven by strong vehicle deliveries and expansion of robo-taxi services. Despite recent struggles, Tesla's shares have gained significantly over the past year, supported by positive analyst outlooks and strategic developments in AI and autonomous driving.